文献速递心脏核医学肿瘤 PET/CT

优化[18F]氟吡啶嗪PET心肌灌注显像方案效率:通过剂量比驱动降低相对残留活性

Optimizing protocol efficiency in [18F]flurpiridaz positron emission tomography myocardial perfusion imaging through dose ratio-driven reduction of relative residual activity.
PubMed 文献 · J Nucl Cardiol · 2026-01-30

本研究分析了115例接受[18F]氟吡啶嗪PET心肌灌注显像的患者,评估负荷与静息注射剂量比及注射间期对残留活性的影响。结果显示,提高负荷/静息剂量比与更低的相对残留活性显著相关(β=-3.41),而注射间期在39分钟内无显著关联。实现相对残留活性<20%的最佳剂量比切点范围为3.2至4.3,可支持连续显像并提高数字PET系统方案效率。

要点

  • 提高负荷/静息剂量比可显著降低相对残留活性。
  • 注射间期在39分钟内对残留活性无显著影响。
  • 剂量比3.2至4.3可使残留活性<20%,支持连续显像。

核心结论

  • 负荷/静息剂量比在3.2至4.3之间可有效将残留活性降至负荷剂量的20%以下,从而支持连续显像并提高数字PET系统方案效率。

研究设计与样本

  • 回顾性分析连续115例接受[18F]氟吡啶嗪PET心肌灌注显像的患者,采用线性回归评估剂量比和注射间期与全局残留活性的关联,并识别最佳剂量比切点。

主要发现

  • 负荷/静息剂量比每增加1单位,相对残留活性显著降低(β=-3.41;95%CI:-4.72至-2.11)。
  • 注射间期在39分钟内每增加1分钟,相对残留活性无显著变化(β=0.03;95%CI:-0.12至0.17)。
  • 实现相对残留活性<20%的最佳剂量比切点范围为3.2至4.3。

关键数值与推荐

  • 相对残留活性计算为第一负荷帧组织活性浓度(kBq/mL)与负荷组织相位活性浓度之比。
  • 最佳剂量比切点范围为3.2至4.3,对应相对残留活性<20%。

临床怎么用

  • 在数字PET系统上,可考虑将负荷/静息剂量比设定在3.2至4.3之间,以降低残留活性并实现连续显像,提高方案效率。

局限性

  • 结论需在较旧的非数字扫描仪上进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: [18F]flurpiridaz is a newly FDA-approved tracer for positron emission tomography myocardial perfusion imaging (PET MPI) with a long half-life and improved physical characteristics. However, its long half-life leads to residual rest activity. Prior trials used 30 to 60 minutes delays between rest and stress injections and proposed stress-to-rest dose ratios of 1:2 to 1:3 to mitigate the potential impact of residual rest counts on the stress myocardial perfusion images. OBJECTIVE: To evaluate the effect of stress-to-rest dose ratio and time interval between injections on residual activity. METHODS: We analyzed consecutive 115 patients who underwent PET MPI with [18F]flurpiridaz. Relative residual activity was calculated as the ratio of tissue activity concentration (kBq/mL) in the first stress frame to that in the stress tissue phase. Linear regression was used to assess the association of dose ratio and injection time interval with global residual activity. The optimal dose ratio cutoff was identified. Mixed-effects models with interaction terms were used to assess whether the effect varied across vascular territories. RESULTS: A total of 115 patients underwent PET MPI. Results showed that increasing the stress-to-rest dose ratio was significantly associated with lower relative residual activity (β = -3.41; 95% confidence interval (CI): -4.72; -2.11 per 1-unit increase), while increasing the time interval between injections up to 39 minutes showed no significant association (β = 0.03 95% CI: -0.12; 0.17 per 1-minute increase) within this time window. The optimal cutoff dose ratio to achieve relative residual activity <20% ranged between 3.2 and 4.3. CONCLUSION: Increasing the stress-to-rest dose ratio between 3.2 and 4.3 effectively reduces residual activity to <20% of the stress dose across all time intervals, thereby enabling back-to-back imaging and improving protocol efficiency on digital PET systems. Further validation is warranted for older, non-digital scanners.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Alwan M, El Yaman A, Al Rifai M, et al. Optimizing protocol efficiency in [18F]flurpiridaz positron emission tomography myocardial perfusion imaging through dose ratio-driven reduction of relative residual activity. J Nucl Cardiol. 2026. PMID: 41621466. doi:10.1016/j.nuclcard.2026.102644

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。